Extension Study to Evaluate Safety and Efficacy of Natalizumab in Japanese Participants With Relapsing-Remitting Multiple Sclerosis
Clinical trial NCT01416155 · COMPLETED
Trial details
- NCT number
- NCT01416155
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2014-12-01
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.